Dheda K - Search Results

1

Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts.

Oelofse S, Esmail A, Diacon AH, Conradie F, Olayanju O, Ngubane N, Howell P, Everitt D, Crook AM, Mendel CM, Wills GH, Olugbosi M, Del Parigi A, Sun E, Calatroni A, Spigelman M, Dheda K. Oelofse S, et al. Among authors: dheda k. Int J Tuberc Lung Dis. 2021 Jun 1;25(6):453-460. doi: 10.5588/ijtld.21.0035. Int J Tuberc Lung Dis. 2021. PMID: 34049607 Free PMC article.

2

Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study.

Dheda K, Shean K, Zumla A, Badri M, Streicher EM, Page-Shipp L, Willcox P, John MA, Reubenson G, Govindasamy D, Wong M, Padanilam X, Dziwiecki A, van Helden PD, Siwendu S, Jarand J, Menezes CN, Burns A, Victor T, Warren R, Grobusch MP, van der Walt M, Kvasnovsky C. Dheda K, et al. Lancet. 2010 May 22;375(9728):1798-807. doi: 10.1016/S0140-6736(10)60492-8. Lancet. 2010. PMID: 20488525 Free article.

3

Extensively drug-resistant tuberculosis: epidemiology and management challenges.

Dheda K, Warren RM, Zumla A, Grobusch MP. Dheda K, et al. Infect Dis Clin North Am. 2010 Sep;24(3):705-25. doi: 10.1016/j.idc.2010.05.001. Infect Dis Clin North Am. 2010. PMID: 20674800 Review.

4

Extensively drug-resistant tuberculosis (XDR-TB) among health care workers in South Africa.

Jarand J, Shean K, O'Donnell M, Loveday M, Kvasnovsky C, Van der Walt M, Adams S, Willcox P, O'Grady J, Zumla A, Dheda K. Jarand J, et al. Among authors: dheda k. Trop Med Int Health. 2010 Oct;15(10):1179-84. doi: 10.1111/j.1365-3156.2010.02590.x. Trop Med Int Health. 2010. PMID: 20831672 Free article.

5

A historical review of XDR tuberculosis in the Western Cape province of South Africa.

Symons G, Shean K, Pietersen E, Van Zyl Smit R, Pool L, Davids M, Willcox P, Dheda K. Symons G, et al. Among authors: dheda k. S Afr Med J. 2011 Sep 5;101(9):636-8. S Afr Med J. 2011. PMID: 21920174

6

2010: the year in review, part I.

Lalloo UG, Nyamande K, Dheda K. Lalloo UG, et al. Among authors: dheda k. Int J Tuberc Lung Dis. 2011 Sep;15(9):1149-53. doi: 10.5588/ijtld.10.0433. Int J Tuberc Lung Dis. 2011. PMID: 21943838 No abstract available.

7

Outcomes of reintroducing anti-tuberculosis drugs following cutaneous adverse drug reactions.

Lehloenya RJ, Todd G, Badri M, Dheda K. Lehloenya RJ, et al. Among authors: dheda k. Int J Tuberc Lung Dis. 2011 Dec;15(12):1649-57. doi: 10.5588/ijtld.10.0698. Int J Tuberc Lung Dis. 2011. PMID: 22118173

8

Diagnostic accuracy of induced sputum LAM ELISA for tuberculosis diagnosis in sputum-scarce patients.

Peter JG, Cashmore TJ, Meldau R, Theron G, van Zyl-Smit R, Dheda K. Peter JG, et al. Among authors: dheda k. Int J Tuberc Lung Dis. 2012 Aug;16(8):1108-12. doi: 10.5588/ijtld.11.0614. Epub 2012 Jun 14. Int J Tuberc Lung Dis. 2012. PMID: 22710609 Free PMC article.

9

Multiple drug hypersensitivity reactions to anti-tuberculosis drugs: five cases in HIV-infected patients.

Lehloenya RJ, Wallace J, Todd G, Dheda K. Lehloenya RJ, et al. Among authors: dheda k. Int J Tuberc Lung Dis. 2012 Sep;16(9):1260-4. doi: 10.5588/ijtld.11.0187. Epub 2012 Jun 28. Int J Tuberc Lung Dis. 2012. PMID: 22747953 Clinical Trial.

10

What is the cost of diagnosis and management of drug resistant tuberculosis in South Africa?

Pooran A, Pieterson E, Davids M, Theron G, Dheda K. Pooran A, et al. Among authors: dheda k. PLoS One. 2013;8(1):e54587. doi: 10.1371/journal.pone.0054587. Epub 2013 Jan 18. PLoS One. 2013. PMID: 23349933 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

384 results

Search Page